No Picture
News

Canaan leaps into UK biotech by co-leading $14M Series A for immuno-oncology upstart Grey Wolf

Checkpoint inhibitors have done wonders for immuno-oncology, but the potent class of drugs doesn’t work across all cancers. To remedy this, UK-based biotech upstart Grey Wolf Therapeutics is working on a fresh approach that does not directly target the… […]